3 Oct 2022

Finished Dosage Forms Portfolio

PDF 729 kB

Centrient Pharmaceuticals is a business-to-business provider of generics FDFs, not marketing the products ourselves. Therefore, we do not compete with our customers in the end market. All our dossiers are readily available for out-licensing to our partners worldwide. We work primarily with Europe-based FDFs manufacturers. Customers can be confident that the origin, traceability, and quality of our products are impeccable. We offer a dual sourcing strategy and procurement excellence for our third-party-produced APIs.

Content provided by our supplier

Centrient Pharmaceuticals

  • NL
  • 2015
    On CPHI since
  • 3
  • 1000 - 4999
Company types
Primary activities
Finished Formulation products Distributor/Buyer
Generic APIs producer

Other Content from Centrient Pharmaceuticals (7)